Principles and applications of halogen bonding in medicinal chemistry and chemical biology

Journal of Medicinal Chemistry

Volumn 56, Issue 4, 2013, Pages 1363-1388

  Wilcken, Rainer ^a,b   Zimmermann, Markus O ^a   Lange, Andreas ^a   Joerger, Andreas C ^b   Boeckler, Frank M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BROMINE; CARBOXYLIC ACID; CHLORINE; CYSTEINE; GLUTAMIC ACID; HALOGEN; HYDROXYL GROUP; IODINE; IODOBENZENE; LEWIS BASE; METHIONINE; MOLECULAR SCAFFOLD; N METHYLACETAMIDE; NITROGEN; SERINE; SULFUR; THREONINE; TYROSINE;

BINDING SITE; BIOCHEMISTRY; BIOLOGY; CALCULATION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; COVALENT BOND; CRYSTAL STRUCTURE; DEIODINATION; DRUG DESIGN; DRUG DEVELOPMENT; ENTROPY; GEOMETRY; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; MOLECULAR SIZE; MOLECULAR WEIGHT; PROCESS OPTIMIZATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTUM CHEMISTRY; REVIEW; SOLVATION; STATIC ELECTRICITY;

EID: 84874632186     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm3012068     Document Type: Review

References (157)

1. Dumas, J. M.; Peurichard, H.; Gomel, M. CX4⋯base interactions as models of weak charge-transfer interactions: comparison with strong charge-transfer and hydrogen-bond interactions J. Chem. Res. 1978, 2, 54-55
2. Clark, T.; Hennemann, M.; Murray, J. S.; Politzer, P. Halogen bonding: the sigma-hole J. Mol. Model. 2007, 13 (2) 291-296
3. Clark, T. σ-Holes. Wiley Interdiscip. Rev.: Comput. Mol. Sci. [Online early access] DOI: 10.1002/wcms.1113. Published Online: Aug 8, 2012.
4. Metrangolo, P.; Meyer, F.; Pilati, T.; Resnati, G.; Terraneo, G. Halogen bonding in supramolecular chemistry Angew. Chem., Int. Ed. 2008, 47 (33) 6114-6127
5. Voth, A. R.; Hays, F. A.; Ho, P. S. Directing macromolecular conformation through halogen bonds Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (15) 6188-6193 (Pubitemid 47186070)
6. Hassel, O. Structural aspects of interatomic charge-transfer bonding Science 1970, 170 (3957) 497-502
7. Hassel, O.; Hvoslef, J. The structure of bromine 1,4-dioxanate Acta Chem. Scand. 1954, 8, 873-873
8. Cody, V.; Murray-Rust, P. Iodine⋯X(O, N, S) intermolecular contacts: models of thyroid hormone-protein binding interactions using information from the Cambridge crystallographic data files J. Mol. Struct. 1984, 112 (3-4) 189-199
9. Parisini, E.; Metrangolo, P.; Pilati, T.; Resnati, G.; Terraneo, G. Halogen bonding in halocarbon-protein complexes: a structural survey Chem. Soc. Rev. 2011, 40 (5) 2267-2278
10. Lu, Y.; Wang, Y.; Zhu, W. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design Phys. Chem. Chem. Phys. 2010, 12 (18) 4543-4551
11. Auffinger, P.; Hays, F. A.; Westhof, E.; Ho, P. S. Halogen bonds in biological molecules Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (48) 16789-16794 (Pubitemid 39601317)
12. The PyMOL Molecular Graphics System, version 1.5.0.4; Schrödinger, LLC: New York.
13. Ramasubbu, N.; Parthasarathy, R.; Murray-Rust, P. Angular preferences of intermolecular forces around halogen centers: preferred directions of approach of electrophiles and nucleophiles around carbon-halogen bond J. Am. Chem. Soc. 1986, 108 (15) 4308-4314
14. Lommerse, J. P. M.; Stone, A. J.; Taylor, R.; Allen, F. H. The nature and geometry of intermolecular interactions between halogens and oxygen or nitrogen J. Am. Chem. Soc. 1996, 118 (13) 3108-3116 (Pubitemid 26135501)
15. Politzer, P.; Murray, J. S.; Clark, T. Halogen bonding: an electrostatically-driven highly directional noncovalent interaction Phys. Chem. Chem. Phys. 2010, 12 (28) 7748-7757
16. Lu, Y.; Shi, T.; Wang, Y.; Yang, H.; Yan, X.; Luo, X.; Jiang, H.; Zhu, W. Halogen bonding-a novel interaction for rational drug design? J. Med. Chem. 2009, 52 (9) 2854-2862
17. Politzer, P.; Lane, P.; Concha, M. C.; Ma, Y. G.; Murray, J. S. An overview of halogen bonding J. Mol. Model. 2007, 13 (2) 305-311 (Pubitemid 46189160)
18. Metrangolo, P.; Murray, J. S.; Pilati, T.; Politzer, P.; Resnati, G.; Terraneo, G. The fluorine atom as a halogen bond donor, viz. a positive site CrystEngComm 2011, 13 (22) 6593-6596
19. Metrangolo, P.; Murray, J. S.; Pilati, T.; Politzer, P.; Resnati, G.; Terraneo, G. Fluorine-centered halogen bonding: a factor in recognition phenomena and reactivity Cryst. Growth Des. 2011, 11 (9) 4238-4246
20. Brickmann, J.; Exner, T. E.; Keil, M.; Marhofer, R. J. Molecular graphics-trends and perspectives J. Mol. Model. 2000, 6 (2) 328-340
21. Brickmann, J.; Exner, T. E.; Gimmler, J.; Lautenschläger, P.; Heiden, W.; Moeckel, G.; Zahn, D. MOLCAD II; MOLCAD GmbH: Darmstadt, Germany; http://www.molcad.de.
22. Bissantz, C.; Kuhn, B.; Stahl, M. A medicinal chemist's guide to molecular interactions J. Med. Chem. 2010, 53 (14) 5061-5084
23. Hardegger, L. A.; Kuhn, B.; Spinnler, B.; Anselm, L.; Ecabert, R.; Stihle, M.; Gsell, B.; Thoma, R.; Diez, J.; Benz, J.; Plancher, J.-M.; Hartmann, G.; Banner, D. W.; Haap, W.; Diederich, F. Systematic investigation of halogen bonding in protein-ligand interactions Angew. Chem., Int. Ed. 2011, 50 (1) 314-318
24. Hardegger, L. A.; Kuhn, B.; Spinnler, B.; Anselm, L.; Ecabert, R.; Stihle, M.; Gsell, B.; Thoma, R.; Diez, J.; Benz, J.; Plancher, J.-M.; Hartmann, G.; Isshiki, Y.; Morikami, K.; Shimma, N.; Haap, W.; Banner, D. W.; Diederich, F. Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments ChemMedChem 2011, 6 (11) 2048-2054
25. Wilcken, R.; Liu, X.; Zimmermann, M. O.; Rutherford, T. J.; Fersht, A. R.; Joerger, A. C.; Boeckler, F. M. Halogen-enriched fragment libraries as leads for drug rescue of mutant p53 J. Am. Chem. Soc. 2012, 134 (15) 6810-6818
26. Riley, K. E.; Hobza, P. Investigations into the nature of halogen bonding including symmetry adapted perturbation theory analyses J. Chem. Theory Comput. 2008, 4 (2) 232-242
27. Kolář, M.; Hobza, P. On Extension of the current biomolecular empirical force field for the description of halogen bonds J. Chem. Theory Comput. 2012, 8 (4) 1325-1333
28. Jorgensen, W. L.; Schyman, P. Treatment of halogen bonding in the OPLS-AA force field: application to potent anti-HIV agents J. Chem. Theory Comput. 2012, 8 (10) 3895-3901
29. Wilcken, R.; Zimmermann, M.; Lange, A.; Zahn, S.; Boeckler, F. Using halogen bonds to address the protein backbone: a systematic evaluation J. Comput-Aided. Mol. Des. 2012, 26 (8) 935-945
30. Kümmel, H. G. A Biography of the Coupled Cluster Method; World Scientific Publishing: Singapore, 2002.
31. Møller, C.; Plesset, M. S. Note on an approximation treatment for many-electron systems Phys. Rev. 1934, 46 (7) 618
32. Pople, J. A.; Binkley, J. S.; Seeger, R. Theoretical models incorporating electron correlation Int. J. Quantum Chem. 1976, 1-19
33. Dobeš, P.; Řezáć, J.; Fanfrlík, J.; Otyepka, M.; Hobza, P. Semiempirical quantum mechanical method PM6-DH2X describes the geometry and energetics of CK2-inhibitor complexes involving halogen bonds well, while the empirical potential fails J. Phys. Chem. B 2011, 115 (26) 8581-8589
34. Steiner, T. The hydrogen bond in the solid state Angew. Chem., Int. Ed. 2002, 41 (1) 49-76
35. Murray, J. S.; Riley, K. E.; Politzer, P.; Clark, T. Directional weak intermolecular interactions: sigma-hole bonding Aust. J. Chem. 2010, 63 (12) 1598-1607
36. Grimme, S.; Antony, J.; Ehrlich, S.; Krieg, H. A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu J. Chem. Phys. 2010, 132, 154104
37. Grimme, S. Semiempirical GGA-type density functional constructed with a long-range dispersion correction J. Comput. Chem. 2006, 27 (15) 1787-1799 (Pubitemid 44672561)
38. Grimme, S. Accurate description of van der Waals complexes by density functional theory including empirical corrections J. Comput. Chem. 2004, 25 (12) 1463-1473
39. Hennemann, M.; Murray, J.; Politzer, P.; Riley, K.; Clark, T. Polarization-induced σ-holes and hydrogen bonding J. Mol. Model. 2012, 18 (6) 2461-2469
40. Riley, K.; Murray, J.; Fanfrlík, J.; Řezáč, J.; Solá, R.; Concha, M.; Ramos, F.; Politzer, P. Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine J. Mol. Model. 2011, 17 (12) 3309-3318
41. Riley, K. E.; Murray, J. S.; Fanfrlik, J.; Rezac, J.; Sola, R. J.; Concha, M. C.; Ramos, F. M.; Politzer, P. Halogen bond tunability II: the varying roles of electrostatic and dispersion contributions to attraction in halogen bonds. J. Mol. Model. [Online early access]. DOI: 10.1007/s00894-00012- 01428-x. Published May 29, 2012.
42. Metrangolo, P.; Resnati, G. Halogen bonding: a paradigm in supramolecular chemistry Chem.-Eur. J. 2001, 7 (12) 2511-2519 (Pubitemid 32594762)
43. Riley, K. E.; Hobza, P. Strength and character of halogen bonds in protein-ligand complexes Cryst. Growth Des. 2011, 11 (10) 4272-4278
44. El Kerdawy, A.; Wick, C. R.; Hennemann, M.; Clark, T. Predicting the sites and energies of noncovalent intermolecular interactions using local properties J. Chem. Inf. Model. 2012, 52 (4) 1061-1071
45. Bauza, A.; Quinonero, D.; Frontera, A.; Deya, P. M. Substituent effects in halogen bonding complexes between aromatic donors and acceptors: a comprehensive ab initio study Phys. Chem. Chem. Phys. 2011, 13 (45) 20371-20379
46. Fedorov, O.; Huber, K.; Eisenreich, A.; Filippakopoulos, P.; King, O.; Bullock, A. N.; Szklarczyk, D.; Jensen, L. J.; Fabbro, D.; Trappe, J.; Rauch, U.; Bracher, F.; Knapp, S. Specific CLK Inhibitors from a novel chemotype for regulation of alternative splicing Chem. Biol. 2011, 18 (1) 67-76
47. Grant, S. K.; Lunney, E. A. Kinase inhibition that hinges on halogen bonds Chem. Biol. 2011, 18 (1) 3-4
48. Riley, K. E.; Murray, J. S.; Politzer, P.; Concha, M. C.; Hobza, P. Br⋯O complexes as probes of factors affecting halogen bonding: interactions of bromobenzenes and bromopyrimidines with acetone J. Chem. Theory Comput. 2008, 5 (1) 155-163
49. Voth, A. R.; Khuu, P.; Oishi, K.; Ho, P. S. Halogen bonds as orthogonal molecular interactions to hydrogen bonds Nat. Chem. 2009, 1 (1) 74-79
50. Wilcken, R.; Zimmermann, M. O.; Lange, A.; Zahn, S.; Kirchner, B.; Boeckler, F. M. Addressing methionine in molecular design through directed sulfur-halogen bonds J. Chem. Theory Comput. 2011, 7 (7) 2307-2315
51. Shields, Z. P.; Murray, J. S.; Politzer, P. Directional tendencies of halogen and hydrogen bonds Int. J. Quantum Chem. 2010, 110 (15) 2823-2832
52. Murray, J.; Lane, P.; Politzer, P. Expansion of the σ-hole concept J. Mol. Model. 2009, 15 (6) 723-729
53. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J.; Meyer, E. F., Jr.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The Protein Data Bank: a computer-based archival file for macromolecular structures J. Mol. Biol. 1977, 112 (3) 535-542 (Pubitemid 8109216)
54. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank Nucleic Acids Res. 2000, 28 (1) 235-242 (Pubitemid 30047768)
55. Neudert, G.; Klebe, G. DSX: a knowledge-based scoring function for the assessment of protein-ligand complexes J. Chem. Inf. Model. 2011, 51 (10) 2731-2745
56. Gohlke, H.; Hendlich, M.; Klebe, G. Knowledge-based scoring function to predict protein-ligand interactions J. Mol. Biol. 2000, 295 (2) 337-356 (Pubitemid 30045364)
57. Mooij, W. T.; Verdonk, M. L. General and targeted statistical potentials for protein-ligand interactions Proteins 2005, 61 (2) 272-287 (Pubitemid 41429135)
58. Muegge, I.; Martin, Y. C. A general and fast scoring function for protein-ligand interactions: a simplified potential approach J. Med. Chem. 1999, 42 (5) 791-804 (Pubitemid 29136170)
59. Gunther, J.; Bergner, A.; Hendlich, M.; Klebe, G. Utilising structural knowledge in drug design strategies: applications using Relibase J. Mol. Biol. 2003, 326 (2) 621-636 (Pubitemid 36279353)
60. Hendlich, M.; Bergner, A.; Gunther, J.; Klebe, G. Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions J. Mol. Biol. 2003, 326 (2) 607-620 (Pubitemid 36279352)
61. Wang, L.; Xie, Z.; Wipf, P.; Xie, X. Q. Residue preference mapping of ligand fragments in the Protein Data Bank J. Chem. Inf. Model. 2011, 51 (4) 807-815
62. Kortagere, S.; Ekins, S.; Welsh, W. J. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships J. Mol. Graphics Modell. 2008, 27 (2) 170-177
63. Lu, Y.; Wang, Y.; Xu, Z.; Yan, X.; Luo, X.; Jiang, H.; Zhu, W. C-X⋯H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity J. Phys. Chem. B 2009, 113 (37) 12615-12621
64. Katz, B. A.; Sprengeler, P. A.; Luong, C.; Verner, E.; Elrod, K.; Kirtley, M.; Janc, J.; Spencer, J. R.; Breitenbucher, J. G.; Hui, H.; McGee, D.; Allen, D.; Martelli, A.; Mackman, R. L. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets Chem. Biol. 2001, 8 (11) 1107-1121 (Pubitemid 33119187)
65. Warmus, J. S.; Flamme, C.; Zhang, L. Y.; Barrett, S.; Bridges, A.; Chen, H.; Gowan, R.; Kaufman, M.; Sebolt-Leopold, J.; Leopold, W.; Merriman, R.; Ohren, J.; Pavlovsky, A.; Przybranowski, S.; Tecle, H.; Valik, H.; Whitehead, C.; Zhang, E. 2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles- O -alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase) Bioorg. Med. Chem. Lett. 2008, 18 (23) 6171-6174
66. Himmel, D. M.; Das, K.; Clark, A. D., Jr.; Hughes, S. H.; Benjahad, A.; Oumouch, S.; Guillemont, J.; Coupa, S.; Poncelet, A.; Csoka, I.; Meyer, C.; Andries, K.; Nguyen, C. H.; Grierson, D. S.; Arnold, E. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains J. Med. Chem. 2005, 48 (24) 7582-7591 (Pubitemid 41698799)
67. Jin, R.; Gouaux, E. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal Biochemistry 2003, 42 (18) 5201-5213 (Pubitemid 36560416)
68. Jin, R.; Banke, T. G.; Mayer, M. L.; Traynelis, S. F.; Gouaux, E. Structural basis for partial agonist action at ionotropic glutamate receptors Nat. Neurosci. 2003, 6 (8) 803-810 (Pubitemid 36929700)
69. Ahmed, A. H.; Wang, S.; Chuang, H. H.; Oswald, R. E. Mechanism of AMPA receptor activation by partial agonists: disulfide trapping of closed lobe conformations J. Biol. Chem. 2011, 286 (40) 35257-35266
70. Gao, H. Y.; Shen, Q. J.; Zhao, X. R.; Yan, X. Q.; Pang, X.; Jin, W. J. Phosphorescent co-crystal assembled by 1,4-diiodotetrafluorobenzene with carbazole based on C-I halogen bonding J. Mater. Chem. 2012, 22 (12) 5336-5343
71. 13C NMR and density functional theory study J. Chem. Phys. 2012, 136 (14) 141101
72. Beck, T.; Krasauskas, A.; Gruene, T.; Sheldrick, G. M. A magic triangle for experimental phasing of macromolecules Acta Crystallogr., Sect. D: Biol. Crystallogr. 2008, 64 (Pt 11) 1179-1182
73. Yu, S. B.; Watson, A. D. Metal-based X-ray contrast media Chem. Rev. 1999, 99 (9) 2353-2378
74. Kumar, S.; Nussinov, R. Close-range electrostatic interactions in proteins ChemBioChem 2002, 3 (7) 604-617 (Pubitemid 36004524)
75. Gilson, M. K.; Zhou, H. X. Calculation of protein-ligand binding affinities Annu. Rev. Biophys. Biomol. Struct. 2007, 36, 21-42 (Pubitemid 46998108)
76. Trbovic, N.; Cho, J. H.; Abel, R.; Friesner, R. A.; Rance, M.; Palmer, A. G., 3rd. Protein side-chain dynamics and residual conformational entropy J. Am. Chem. Soc. 2009, 131 (2) 615-622
77. Dolman, N. P.; More, J. C.; Alt, A.; Knauss, J. L.; Pentikainen, O. T.; Glasser, C. R.; Bleakman, D.; Mayer, M. L.; Collingridge, G. L.; Jane, D. E. Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists J. Med. Chem. 2007, 50 (7) 1558-1570 (Pubitemid 46564377)
78. Alushin, G. M.; Jane, D.; Mayer, M. L. Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists Neuropharmacology 2011, 60 (1) 126-134
79. Best, R. B.; Clarke, J.; Karplus, M. The origin of protein sidechain order parameter distributions J. Am. Chem. Soc. 2004, 126 (25) 7734-7735 (Pubitemid 38812739)
80. Lovell, S. C.; Word, J. M.; Richardson, J. S.; Richardson, D. C. The penultimate rotamer library Proteins 2000, 40 (3) 389-408 (Pubitemid 30624447)
81. Engel, J. C.; Doyle, P. S.; Hsieh, I.; McKerrow, J. H. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection J. Exp. Med. 1998, 188 (4) 725-734 (Pubitemid 28387935)
82. Ferreira, R. S.; Simeonov, A.; Jadhav, A.; Eidam, O.; Mott, B. T.; Keiser, M. J.; McKerrow, J. H.; Maloney, D. J.; Irwin, J. J.; Shoichet, B. K. Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors J. Med. Chem. 2010, 53 (13) 4891-4905
83. Wei, B. Q.; Baase, W. A.; Weaver, L. H.; Matthews, B. W.; Shoichet, B. K. A model binding site for testing scoring functions in molecular docking J. Mol. Biol. 2002, 322 (2) 339-355
84. Shoichet, B. K.; Leach, A. R.; Kuntz, I. D. Ligand solvation in molecular docking Proteins 1999, 34 (1) 4-16 (Pubitemid 29019528)
85. Meng, E. C.; Shoichet, B. K.; Kuntz, I. D. Automated docking with grid-based energy evaluation J. Comput. Chem. 1992, 13 (4) 505-524
86. Njoroge, F. G.; Vibulbhan, B.; Pinto, P.; Strickland, C.; Bishop, W. R.; Nomeir, A.; Girijavallabhan, V. Enhanced FTase activity achieved via piperazine interaction with catalytic zinc Bioorg. Med. Chem. Lett. 2006, 16 (4) 984-988 (Pubitemid 43059865)
87. Ho, B. K.; Curmi, P. M. G. Twist and shear in beta-sheets and beta-ribbons J. Mol. Biol. 2002, 317 (2) 291-308
88. Nesloney, C. L.; Kelly, J. W. Progress towards understanding beta-sheet structure Bioorg. Med. Chem. 1996, 4 (6) 739-766 (Pubitemid 26202374)
89. Weatherford, D. W.; Salemme, F. R. Conformations of twisted parallel beta-sheets and the origin of chirality in protein structures Proc. Natl. Acad. Sci. U.S.A. 1979, 76 (1) 19-23
90. Eneqvist, T.; Lundberg, E.; Karlsson, A.; Huang, S.; Santos, C. R.; Power, D. M.; Sauer-Eriksson, A. E. High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine J. Biol. Chem. 2004, 279 (25) 26411-26416 (Pubitemid 38798793)
91. Sudlow, G.; Birkett, D. J.; Wade, D. N. The characterization of two specific drug binding sites on human serum albumin Mol. Pharmacol. 1975, 11 (6) 824-832
92. Ghuman, J.; Zunszain, P. A.; Petitpas, I.; Bhattacharya, A. A.; Otagiri, M.; Curry, S. Structural basis of the drug-binding specificity of human serum albumin J. Mol. Biol. 2005, 353 (1) 38-52 (Pubitemid 41338838)
93. Rohde, L. A. H.; Ahring, P. K.; Jensen, M. L.; Nielsen, E. Ø.; Peters, D.; Helgstrand, C.; Krintel, C.; Harpsøe, K.; Gajhede, M.; Kastrup, J. S.; Balle, T. Intersubunit bridge formation governs agonist efficacy at nicotinic acetylcholine α4β2 receptors J. Biol. Chem. 2012, 287 (6) 4248-4259
94. Lemke, C. T.; Goudreau, N.; Zhao, S.; Hucke, O.; Thibeault, D.; Llinàs-Brunet, M.; White, P. W. Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335 J. Biol. Chem. 2011, 286 (13) 11434-11443
95. Benjahad, A.; Guillemont, J.; Andries, K.; Nguyen, C. H.; Grierson, D. S. 3-Iodo-4-phenoxypyridinones (IOPY's), a new family of highly potent non-nucleoside inhibitors of HIV-1 reverse transcriptase Bioorg. Med. Chem. Lett. 2003, 13 (24) 4309-4312 (Pubitemid 37490809)
96. Bollini, M.; Domaoal, R. A.; Thakur, V. V.; Gallardo-Macias, R.; Spasov, K. A.; Anderson, K. S.; Jorgensen, W. L. Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents J. Med. Chem. 2011, 54 (24) 8582-8591
97. Baumli, S.; Endicott, J. A.; Johnson, L. N. Halogen bonds form the basis for selective P-TEFb inhibition by DRB Chem. Biol. 2010, 17 (9) 931-936
98. Huber, K.; Brault, L.; Fedorov, O.; Gasser, C.; Filippakopoulos, P.; Bullock, A. N.; Fabbro, D.; Trappe, J.; Schwaller, J.; Knapp, S.; Bracher, F. 7,8-Dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes J. Med. Chem. 2011, 55 (1) 403-413
99. Popowicz, G. M.; Domling, A.; Holak, T. A. The structure-based design of Mdm2/Mdmx-p53 inhibitors gets serious Angew. Chem., Int. Ed. 2011, 50 (12) 2680-2688
100. Vogel, S. M.; Bauer, M. R.; Joerger, A. C.; Wilcken, R.; Brandt, T.; Veprintsev, D. B.; Rutherford, T. J.; Fersht, A. R.; Boeckler, F. M. Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2 Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (42) 16906-16910
101. Graves, B.; Thompson, T.; Xia, M.; Janson, C.; Lukacs, C.; Deo, D.; Di Lello, P.; Fry, D.; Garvie, C.; Huang, K. S.; Gao, L.; Tovar, C.; Lovey, A.; Wanner, J.; Vassilev, L. T. Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (29) 11788-11793
102. Grasberger, B. L.; Lu, T.; Schubert, C.; Parks, D. J.; Carver, T. E.; Koblish, H. K.; Cummings, M. D.; LaFrance, L. V.; Milkiewicz, K. L.; Calvo, R. R.; Maguire, D.; Lattanze, J.; Franks, C. F.; Zhao, S.; Ramachandren, K.; Bylebyl, G. R.; Zhang, M.; Manthey, C. L.; Petrella, E. C.; Pantoliano, M. W.; Deckman, I. C.; Spurlino, J. C.; Maroney, A. C.; Tomczuk, B. E.; Molloy, C. J.; Bone, R. F. Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells J. Med. Chem. 2005, 48 (4) 909-912 (Pubitemid 40270436)
103. Parks, D. J.; Lafrance, L. V.; Calvo, R. R.; Milkiewicz, K. L.; Gupta, V.; Lattanze, J.; Ramachandren, K.; Carver, T. E.; Petrella, E. C.; Cummings, M. D.; Maguire, D.; Grasberger, B. L.; Lu, T. 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR Bioorg. Med. Chem. Lett. 2005, 15 (3) 765-770
104. Kantsadi, A. L.; Hayes, J. M.; Manta, S.; Skamnaki, V. T.; Kiritsis, C.; Psarra, A.-M. G.; Koutsogiannis, Z.; Dimopoulou, A.; Theofanous, S.; Nikoleousakos, N.; Zoumpoulakis, P.; Kontou, M.; Papadopoulos, G.; Zographos, S. E.; Komiotis, D.; Leonidas, D. D. The σ-hole phenomenon of halogen atoms forms the structural basis of the strong inhibitory potency of C5 halogen substituted glucopyranosyl nucleosides towards glycogen phosphorylase b ChemMedChem 2012, 7 (4) 722-732
105. Xu, Z.; Liu, Z.; Chen, T.; Chen, T.; Wang, Z.; Tian, G.; Shi, J.; Wang, X.; Lu, Y.; Yan, X.; Wang, G.; Jiang, H.; Chen, K.; Wang, S.; Xu, Y.; Shen, J.; Zhu, W. Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors J. Med. Chem. 2011, 54 (15) 5607-5611
106. Maillard, M. C.; Hom, R. K.; Benson, T. E.; Moon, J. B.; Mamo, S.; Bienkowski, M.; Tomasselli, A. G.; Woods, D. D.; Prince, D. B.; Paddock, D. J.; Emmons, T. L.; Tucker, J. A.; Dappen, M. S.; Brogley, L.; Thorsett, E. D.; Jewett, N.; Sinha, S.; John, V. Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase J. Med. Chem. 2007, 50 (4) 776-781 (Pubitemid 46332990)
107. Joerger, A. C.; Ang, H. C.; Fersht, A. R. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (41) 15056-15061 (Pubitemid 44583163)
108. Boeckler, F. M.; Joerger, A. C.; Jaggi, G.; Rutherford, T. J.; Veprintsev, D. B.; Fersht, A. R. Targeted rescue of a destabilized mutant of p53 by an in silico screened drug Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (30) 10360-10365
109. Wilcken, R.; Wang, G.; Boeckler, F. M.; Fersht, A. R. Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (34) 13584-13589
110. Lu, Y.-X.; Zou, J.-W.; Fan, J.-C.; Zhao, W.-N.; Jiang, Y.-J.; Yu, Q.-S. Ab initio calculations on halogen-bonded complexes and comparison with density functional methods J. Comput. Chem. 2009, 30 (5) 725-732
111. Grimme, S. Density functional theory with London dispersion corrections Wiley Interdiscip. Rev.: Comput. Mol. Sci. 2011, 1 (2) 211-228
112. Zimmermann, M.; Lange, A.; Boeckler, F. M. Unpublished results.
113. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. The development and use of quantum-mechanical molecular-models. 76. Am1-a new general-purpose quantum-mechanical molecular-model J. Am. Chem. Soc. 1985, 107 (13) 3902-3909
114. Stewart, J. J. P. Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements J. Mol. Model. 2007, 13 (12) 1173-1213 (Pubitemid 47629446)
115. Ibrahim, M. A. A. Performance assessment of semiempirical molecular orbital methods in describing halogen bonding: quantum mechanical and quantum mechanical/molecular mechanical-molecular dynamics study J. Chem. Inf. Model. 2011, 51 (10) 2549-2559
116. Řezáč, J.; Hobza, P. A halogen-bonding correction for the semiempirical PM6 method Chem. Phys. Lett. 2011, 506 (4-6) 286-289
117. Halgren, T. A. Merck molecular force field. 1. Basis, form, scope, parameterization, and performance of MMFF94 J. Comput. Chem. 1996, 17 (5-6) 490-519 (Pubitemid 126567067)
118. Wang, J. M.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and testing of a general amber force field J. Comput. Chem. 2004, 25 (9) 1157-1174
119. Wang, J. M.; Wang, W.; Kollman, P. A.; Case, D. A. Automatic atom type and bond type perception in molecular mechanical calculations J. Mol. Graphics Modell. 2006, 25 (2) 247-260 (Pubitemid 44363172)
120. Rendine, S.; Pieraccini, S.; Forni, A.; Sironi, M. Halogen bonding in ligand-receptor systems in the framework of classical force fields Phys. Chem. Chem. Phys. 2011, 13 (43) 19508-19516
121. Ibrahim, M. A. A. Molecular mechanical study of halogen bonding in drug discovery J. Comput. Chem. 2011, 32 (12) 2564-2574
122. Ibrahim, M. A. A. AMBER empirical potential describes the geometry and energy of noncovalent halogen interactions better than advanced semiempirical quantum mechanical method PM6-DH2X J. Phys. Chem. B 2012, 116 (11) 3659-3669
123. Carter, M.; Rappe, A. K.; Ho, P. S. Scalable anisotroplic shape and electrostatic models for biological bromine halogen bonds J. Chem. Theory Comput. 2012, 8 (7) 2461-2473
124. Warren, G. L.; Andrews, C. W.; Capelli, A. M.; Clarke, B.; LaLonde, J.; Lambert, M. H.; Lindvall, M.; Nevins, N.; Semus, S. F.; Senger, S.; Tedesco, G.; Wall, I. D.; Woolven, J. M.; Peishoff, C. E.; Head, M. S. A critical assessment of docking programs and scoring functions J. Med. Chem. 2006, 49 (20) 5912-5931 (Pubitemid 44484938)
125. Jones, G.; Willett, P.; Glen, R. C. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation J. Mol. Biol. 1995, 245 (1) 43-53
126. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 1997, 267 (3) 727-748 (Pubitemid 27170693)
127. Eldridge, M. D.; Murray, C. W.; Auton, T. R.; Paolini, G. V.; Mee, R. P. Empirical scoring functions. 1. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes J. Comput-Aided. Mol. Des. 1997, 11 (5) 425-445 (Pubitemid 127505895)
128. Murray, C. W.; Auton, T. R.; Eldridge, M. D. Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model J. Comput-Aided. Mol. Des. 1998, 12 (5) 503-519 (Pubitemid 128512820)
129. Kuhn, B.; Fuchs, J. E.; Reutlinger, M.; Stahl, M.; Taylor, N. R. Rationalizing tight ligand binding through cooperative interaction networks J. Chem. Inf. Model. 2011, 51 (12) 3180-3198
130. Paulini, R.; Muller, K.; Diederich, F. Orthogonal multipolar interactions in structural chemistry and biology Angew. Chem., Int. Ed. 2005, 44 (12) 1788-1805
131. Muley, L.; Baum, B.; Smolinski, M.; Freindorf, M.; Heine, A.; Klebe, G.; Hangauer, D. G. Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors J. Med. Chem. 2010, 53 (5) 2126-2135
132. Baum, B.; Muley, L.; Smolinski, M.; Heine, A.; Hangauer, D.; Klebe, G. Non-additivity of functional group contributions in protein ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry J. Mol. Biol. 2010, 397 (4) 1042-1054
133. Gomilsek, J. P.; Arcon, I.; de Panfilis, S.; Kodre, A. X-ray absorption in atomic iodine in the K-edge region Phys. Rev. A 2009, 79 (3) 032514
134. Hamuy, R.; Berman, B. Treatment of herpes simplex virus infections with topical antiviral agents Eur. J. Dermatol. 1998, 8 (5) 310-319 (Pubitemid 28341834)
135. Kudenchuk, P. J.; Cobb, L. A.; Copass, M. K.; Cummins, R. O.; Doherty, A. M.; Fahrenbruch, C. E.; Hallstrom, A. P.; Murray, W. A.; Olsufka, M.; Walsh, T. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation N. Engl. J. Med. 1999, 341 (12) 871-878 (Pubitemid 29427049)
136. Rosenbaum, M. B.; Chiale, P. A.; Haedo, A.; Lazzari, J. O.; Elizari, M. V. Ten years of experience with amiodarone Am. Heart J. 1983, 106 (4, Part 2) 957-964
137. Slagt, V. F.; de Vries, A. H. M.; de Vries, J. G.; Kellogg, R. M. Practical aspects of carbon-carbon cross-coupling reactions using heteroarenes Org. Process Res. Dev. 2010, 14 (1) 30-47
138. Busacca, C. A.; Fandrick, D. R.; Song, J. J.; Senanayake, C. H. The growing impact of catalysis in the pharmaceutical industry Adv. Synth. Catal. 2011, 353 (11-12) 1825-1864
139. Djakovitch, L.; Batail, N.; Genelot, M. Recent advances in the synthesis of N-containing heteroaromatics via heterogeneously transition metal catalysed cross-coupling reactions Molecules 2011, 16 (6) 5241-5267
140. Sasson, Y. Formation of Carbon-Halogen Bonds (Cl, Br, I). In The Chemistry of Halides, Pseudo-Halides and Azides; The Chemistry of Function Groups, Supplement D2; John Wiley & Sons, Ltd.: Chichester, U.K., 2004; pp 535-628.
141. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 2001, 46 (1-3) 3-26 (Pubitemid 33653411)
142. Hann, M. M. Molecular obesity, potency and other addictions in drug discovery MedChemComm 2011, 2 (5) 349-355
143. Hughes, J. D.; Blagg, J.; Price, D. A.; Bailey, S.; Decrescenzo, G. A.; Devraj, R. V.; Ellsworth, E.; Fobian, Y. M.; Gibbs, M. E.; Gilles, R. W.; Greene, N.; Huang, E.; Krieger-Burke, T.; Loesel, J.; Wager, T.; Whiteley, L.; Zhang, Y. Physiochemical drug properties associated with in vivo toxicological outcomes Bioorg. Med. Chem. Lett. 2008, 18 (17) 4872-4875
144. Gleeson, M. P. Generation of a set of simple, interpretable ADMET rules of thumb J. Med. Chem. 2008, 51 (4) 817-834 (Pubitemid 351304691)
145. Waring, M. J. Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability Bioorg. Med. Chem. Lett. 2009, 19 (10) 2844-2851
146. Keseru, G. M.; Makara, G. M. The influence of lead discovery strategies on the properties of drug candidates Nat. Rev. Drug Discovery 2009, 8 (3) 203-212
147. Leeson, P. D.; Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry Nat. Rev. Drug Discovery 2007, 6 (11) 881-890 (Pubitemid 350042396)
148. Zhang, C.; Kenny, J. R.; Le, H.; Deese, A.; Ford, K. A.; Lightning, L. K.; Fan, P. W.; Driscoll, J. P.; Halladay, J. S.; Hop, C. E.; Khojasteh, S. C. Novel mechanism for dehalogenation and glutathione conjugation of dihalogenated anilines in human liver microsomes: evidence for ipso glutathione addition Chem. Res. Toxicol. 2011, 24 (10) 1668-1677
149. Manna, D.; Mugesh, G. Regioselective deiodination of thyroxine by iodothyronine deiodinase mimics: an unusual mechanistic pathway involving cooperative chalcogen and halogen bonding J. Am. Chem. Soc. 2012, 134 (9) 4269-4279
150. Nascimento, A. S.; Dias, S. M.; Nunes, F. M.; Aparicio, R.; Ambrosio, A. L. B.; Bleicher, L.; Figueira, A. C. M.; Santos, M. A. M.; Neto, M. D.; Fischer, H.; Togashi, M.; Craievich, A. F.; Garratt, R. C.; Baxter, J. D.; Webb, P.; Polikarpov, I. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function J. Mol. Biol. 2006, 360 (3) 586-598 (Pubitemid 43975107)
151. Bayse, C. A.; Rafferty, E. R. Is halogen bonding the basis for iodothyronine deiodinase activity? Inorg. Chem. 2010, 49 (12) 5365-5367
152. Valverde, C.; Orozco, A.; Becerra, A.; Jeziorski, M. C.; Villalobos, P.; Solis, J. C. Halometabolites and cellular dehalogenase systems: an evolutionary perspective Int. Rev. Cytol. 2004, 234, 143-199 (Pubitemid 38509222)
153. Isin, E. M.; Guengerich, F. P. Complex reactions catalyzed by cytochrome P450 enzymes Biochim. Biophys. Acta 2007, 1770 (3) 314-329 (Pubitemid 46157073)
154. Nademanee, K.; Piwonka, R. W.; Singh, B. N.; Hershman, J. M. Amiodarone and thyroid function Prog. Cardiovasc. Dis. 1989, 31 (6) 427-437 (Pubitemid 19128264)
155. Lam, P. Y. S.; Clark, C. G.; Smallwood, A. M.; Alexander, R. S. Structure-Based Drug Design Utilizing Halogen Bonding: Factor Xa Inhibitors. Abstracts of Papers, 238th National Meeting of the American Chemical Society; American Chemical Society: Washington, DC, U.S., 2009.
156. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 2001, 46 (1-3) 3-26 (Pubitemid 33653411)
157. Oprea, T. I.; Davis, A. M.; Teague, S. J.; Leeson, P. D. Is there a difference between leads and drugs? A historical perspective J. Chem. Inf. Comput. Sci. 2001, 41 (5) 1308-1315